Evidence of meeting #37 for Health in the 45th Parliament, 1st session. (The original version is on Parliament’s site, as are the minutes.) The winning word was industry.

A video is available from Parliament.

On the agenda

Members speaking

Before the committee

Godard  Director General, Natural and Non-Prescription Health Products Directorate, Department of Health
O'Connor  Director General, Health Product Compliance Directorate, Department of Health

The Chair Liberal Sukh Dhaliwal

I call this meeting to order. Welcome to meeting number 37 of the House of Commons Standing Committee on Health.

Today's meeting is taking place in a hybrid format, pursuant to the Standing Orders.

I would like to remind participants of the following points: Please wait until I recognize you by name before speaking. For those participating by video conference, click on the microphone icon to activate your mic, and please mute yourself when you are not speaking. At the bottom of your screen, you can select the appropriate channel for interpretation of floor, English or French. For members in the room, if you wish to speak, please raise your hand. For members on Zoom, please use the “raise hand” function.

This is a reminder that all comments should be addressed through the chair. The clerk and I will manage the speaking order as best as we can. We appreciate your patience and understanding in this regard.

Pursuant to the order of reference adopted by the House on Tuesday, March 10, 2026, the committee shall commence its clause-by-clause consideration of Bill C-224, an act to amend the Food and Drugs Act regarding natural health products.

I would now like to welcome our witnesses. The first witness is the sponsor of the bill, member of Parliament Mr. Blaine Calkins.

Mr. Calkins, you have five minutes for opening remarks. Please go ahead.

4:30 p.m.

Conservative

Blaine Calkins Conservative Ponoka—Didsbury, AB

Thank you, Chair.

Members of the committee, thanks for inviting me here to discuss my private member's bill, Bill C-224, which passed at second reading—unanimously, I might add—on May 10, 2026.

As you may know, this legislation is the successor to the bill I had in the previous Parliament, Bill C-368, which was adopted by this same committee in December 2024.

Both of my bills have had the same intent, which is to undo changes made by Bill C-47, the budget implementation bill, back in the spring of 2023. These changes came as a part of the infamous omnibus budget bill brought forth by the Liberals that put natural health products under the purview of the therapeutic drugs regime.

In plain language, this means that natural health products in Canada—such as vitamins and minerals, other supplements, electrolytes and so on—were put in the same regulatory regime as the pharmaceutical drugs that you would normally have to get a prescription for. I know not a single person who would look at both of those categories of products and say that they're the same thing. As a matter of fact, the idea would be practically laughable, yet here we are.

The bills that I sponsored, Bill C-368 and now Bill C-224, are very popular widely across the Canadian public and with everybody who's involved in the industry. These proposed changes were so unpopular that they were snuck into Bill C-47. As a matter of fact, nobody even knew about those four little clauses in that bill. Nobody was consulted. The industry, consumers, producers, small businesses, practitioners, women, Chinese traditional medicine practitioners, Ayurvedic medicine practitioners, indigenous traditional medicine practitioners and Canadians at large were not consulted.

For those at home who did not follow the proceedings of Bill C-368 or for those members who did not serve in the last Parliament, Canadians noticed, and they weren't happy. I've never received more correspondence in my office than I did with the postcards asking that the controversial changes to the Food and Drugs Act in clauses 500 to 504 of Bill C-47 be reversed. To members of all parties, today we have a chance to reverse some of these changes.

I would like to begin by stating one essential statistic: Over 80% of Canadians rely on products such as protein powders, vitamins, probiotics, electrolytes and the like in their daily lives. This means that the majority of the members and voters in your riding were affected by the government's handling of this industry. From this very statistic, everything else flows. Natural health products are not just a small sector of the economy but an integral part of people's daily lives as they take care of their own health needs.

It's also a sector that generates significant economic activity. According to an economic impact report from the Canadian Health Food Association, natural health products are a $5.5-billion industry that generates over $200 million in GST alone to the federal government's coffers. The industry also provides 54,000 people with jobs, from manufacturing straight through to retail, and this number does not even include the numbers of indirect jobs, such as those in packaging and shipping.

The government should be doing what it can to nurture this sector. Instead, it is saddling it with more layers of bureaucratic regulations and red tape, while the competitors south of us remain unconstrained. I should note that consumers can still access U.S. natural health products through a 90-day import rule for personal supply. This unregulated mail-order trade has already cost the industry at least $450 million, if not more, in forgone or lost revenue.

The situation is unfortunate. At a time when Canadian businesses face increased hurdles from tariffs and stiff competition from our southern neighbour, they need to be supported by this government and by Health Canada.

Our supplements industry is one of the best-regulated industries in the world. In fact, IADSA, the global association of the food supplement sector, has previously stated that “Canada has been a world leader in the regulation of dietary supplements.” That was before Bill C-47.

By modifying the framework governing natural health products, the government risks stifling Canadian industry, investment and ingenuity and forcing consumers to look elsewhere for products that are inferior to Canadian products.

One thing I would like to highlight is that I drafted Bill C-224 to exclude nicotine replacement products from the NHP regimen, something that was not present in the unamended copy of Bill C-368. Excluding these products was supported by all parties during the last Parliament, and I was glad to ensure that this was reflected in Bill C-224.

In my view, Bill C-224, as drafted, is already adequate for the purpose and the intent for which it was drafted. While I would prefer that the bill pass unamended, that decision is ultimately up to the members of this committee. What I believe is that Canadians have the right to make the health choices that are best for them and their families.

Let's ensure that Canadian businesses remain competitive and that Canadians maintain their access to safe, made-in-Canada, reliable supplements.

Thank you, Mr. Chair.

The Chair Liberal Sukh Dhaliwal

Thank you, Mr. Calkins. That was perfect timing.

We'll start with Ms. Dancho for five minutes.

Please go ahead.

Raquel Dancho Conservative Kildonan—St. Paul, MB

Thank you, Mr. Chair.

First of all, Mr. Calkins, I want to sincerely thank you for your efforts on behalf of the millions of Canadians who take natural health products daily and rely on them. I believe you said 80% of Canadians take some form of natural health products. Thank you for your hard work to ensure that this industry thrives in Canada and that I and others have choices on the shelf. Thank you very much for your hard work.

I want to talk a little about the inspiration for this bill. I understand that it was really back in 2023 when the natural health product industry felt under attack by the Liberal government's actions. Is that where this inspiration came from, and is that why you brought this bill forward?

4:35 p.m.

Conservative

Blaine Calkins Conservative Ponoka—Didsbury, AB

Yes.

As you may recall, Ms. Dancho, you and I were both elected during that time. The omnibus budget bill implementation act, Bill C-47, did make some changes. This is something that the bureaucracy at Health Canada is well known for trying to do. They've tried to do it in several Parliaments. They even did it when Stephen Harper was the prime minister. They snuck this stuff in.

As I said, nobody even knew about this. There were no consultations. Nobody in the industry knew that these provisions were coming. Just four little clauses in a big 800-page bill drastically changed a natural health product into a therapeutic product. Well, you don't need a prescription or a doctor's referral, generally. Sometimes doctors refer these things, but you don't generally need to get a doctor's permission to take vitamin C or zinc or whatever it is that you might want to take.

The impetus of my bill was basically from my wife looking at me and saying, “Hey, I went to the health food store and I saw this postcard here.” I looked at the postcard, and the postcards started coming into my office. We had hundreds of these postcards, and I'm sure every member of Parliament who was here at the time had the same. There were massive campaigns from consumers, practitioners and businesses saying that this was an unnecessary overreach by Health Canada and the Liberal government, so I decided to do something about it.

4:40 p.m.

Conservative

Raquel Dancho Conservative Kildonan—St. Paul, MB

Thank you very much.

Some of those making the argument against your bill are making it seem as though there was no regulation on natural health products prior to 2023, which couldn't be further from the truth. Mr. Calkins, is it not the case that if I go to a health food store, the options that I see all have natural product numbers and that this means they are both regulated and licensed by Health Canada?

4:40 p.m.

Conservative

Blaine Calkins Conservative Ponoka—Didsbury, AB

Absolutely, that's the case. Any natural health product in Canada that makes a health claim has a natural product number on it. That number is a premarket number that has to be granted to the manufacturer or the distributor in order for them to legally put it on a shelf in Canada. It's premarket approval.

This is not what happens everywhere else in the world. As a matter of fact, in the United States, they don't have premarket approval. You can just manufacture whatever you want and throw it on the shelf. If there's a problem with it, later the Food and Drug Administration, the FDA, will come and take it off the shelf or stop the sale, but they don't have pre-approval down there.

We already have regulatory and bureaucratic hurdles in Canada to get a product to the market. I think most Canadians are okay with that notion and concept, but they don't agree with what the changes in Bill C-47 would have done, which would be to make the process for getting vitamin C onto the market the same as the process to get a chemical drug onto the market. I think that's where the overreach and over-regulation come into play. There are massive costs for site licences so that you can be in a place where you can register that natural product number. That was the issue.

4:40 p.m.

Conservative

Raquel Dancho Conservative Kildonan—St. Paul, MB

Just building on that in particular, it was actually this committee back in 1998, during the Liberal Chrétien government, that adopted, I believe, several recommendations that set forth quite an advanced system for regulating natural health products—a leader in the world. Something, as you know, that was important about that was that it distinguished them from pharmaceutical drugs because, of course, they are different. It made it risk-based and proportionate.

Can you comment on the importance and the difference and, again, why you brought this bill forward—because natural health products are not pharmaceuticals and therefore should not be regulated in the same way?

4:40 p.m.

Conservative

Blaine Calkins Conservative Ponoka—Didsbury, AB

We heard expert witnesses before this committee. In previous Parliaments, we heard on Bill C-368 as well that natural health products are basically just refined food products. They're more aligned with food and more akin to food, and they should not be governed and regulated in the same way as a therapeutic drug, a cancer treatment drug or other things like that.

People generally take these things as a means of prevention. They're trying to replace something that they think they're missing from their diet or from their nutritional requirements. They take them as things that might help get their body and their health in balance. As I said, 80% of Canadians rely on these things. To treat them like they're a therapeutic drug is simply, in my estimation, nonsensical.

Now, I understand that there are concerns about these things, but we had a very well-regulated industry, and there was no need to go this extra bit of distance that the government is going right now. There's no need.

4:40 p.m.

Conservative

Raquel Dancho Conservative Kildonan—St. Paul, MB

Thank you very much.

The Chair Liberal Sukh Dhaliwal

We'll go now to Dr. Eyolfson for five minutes.

Please go ahead.

Doug Eyolfson Liberal Winnipeg West, MB

Thank you, Mr. Chair.

Mr. Calkins, I congratulate you on your work, particularly in removing nicotine products from this exemption. As a member of the 80% of the public who take natural health products, namely high-dose vitamins C and D on the advice of my cardiologist, I do understand. I shouldn't need a prescription for vitamin C or D, and I don't.

I've heard from a couple of witnesses that natural health products are not medicines and they do not make claims to be medicines, but we discussed several examples that contradict this.

I spoke of this in the last meeting: St. John's wort. This is a natural health product. It's marketed for the treatment of depression and for symptoms of menopause. The active ingredient has the same mechanism of action as common anti-depressants similar to the class of fluoxetine, better known as Prozac. This product also has a similar risk of serious interactions with a number of prescriptions and over-the-counter medications. This product also has an additional effect similar to an older form of anti-depressant known as MAO inhibitors, which, themselves, are now very rarely prescribed because they can have serious interactions with medicines, as well as with a number of foods.

This is a medicine. It claims to be a medicine. It claims to have a therapeutic effect. It has the same mechanism of action and side effect profile as prescription medications.

We have other examples of this—turmeric, a natural health product for joint inflammation. This has been linked to some very serious liver conditions. Even vitamins, as much as I'm not advocating for a prescription for them, are low risk but not zero risk. If someone was taking the anticoagulant warfarin to prevent strokes and certain conditions, if they take vitamin K, it counteracts that and gives an increased risk of stroke. In fact, when I'm practising medicine, vitamin K is actually the treatment of choice for someone who comes in and their blood is too thin due to too much warfarin.

Considering that these products make these medical claims and have substantial risks like medicines, it doesn't make sense to me that removing the same safeguards for the public as prescription medicines would be in the interest of public safety.

This is my first question: If a prescription medication is, for any reason, found to have a risk to the public, Health Canada regulations permit the timely suspensions of the availability of these products to protect the public. If a natural health product is found to pose a similar risk, why would we not want to afford the public the same ability to suspend its distribution and recall it for public safety?

4:45 p.m.

Conservative

Blaine Calkins Conservative Ponoka—Didsbury, AB

Mr. Eyolfson, let me just clarify a few of the things that I think are actually not factually true in the premise of your question.

Natural health products don't make medical claims; they make health claims. They make health benefit claims, not medical claims. That is a key difference, and as a medical doctor I would have thought that you would have known the difference. Health Canada already has a lot of the ability to do exactly what you suggested—

Doug Eyolfson Liberal Winnipeg West, MB

However, I need to correct—

4:45 p.m.

Conservative

Blaine Calkins Conservative Ponoka—Didsbury, AB

Hang on. Let me finish my answer.

The Chair Liberal Sukh Dhaliwal

One person at a time....

4:45 p.m.

Conservative

Blaine Calkins Conservative Ponoka—Didsbury, AB

Mr. Eyolfson, in reference to what you asked about Health Canada's powers right now, Health Canada pre-approves these natural product numbers. They can stop the sale at any time for any of these products if they want. This is prior to even Bill C-47. They have border power for personal use imports and what can come into the country if they want to use them. They're able to seize any of the products that they need to. They have powers in the law and the regulations for that. They can revoke a site licence for a manufacturer, a package and labeller, or an importer. They can mandate a label change any time they want.

If there was an issue with a particular natural health product, which you were just talking about, Health Canada could have done this before. They didn't need Bill C-47 changes to add warnings, for example. They can inspect any site licence—

The Chair Liberal Sukh Dhaliwal

We will go to Dr. Eyolfson. This is his time.

Doug Eyolfson Liberal Winnipeg West, MB

I'm sorry that I have to cut you off there, but I have to correct something you've said. This medication, St. John's wort, does, in fact, claim to treat depression and has the same mechanism of action. It is a medicine and should be regulated as such.

4:45 p.m.

Conservative

Blaine Calkins Conservative Ponoka—Didsbury, AB

So is acetylsalicylic acid, and I don't see you asking to regulate willow bark.

The Chair Liberal Sukh Dhaliwal

Mr. Calkins, the floor is with me.

We have Madame Gaudreau for five minutes.

Please go ahead.

Marie-Hélène Gaudreau Bloc Laurentides—Labelle, QC

Thank you, Mr. Chair.

Let's go back to the whole process. I wasn't on the Standing Committee on Health in the last Parliament. As you'll remember, I was with you on the Standing Committee on Procedure and House Affairs. My colleague Luc Thériault was the one who participated in the seven meetings on Bill C‑368, proposing amendments that aligned with our values.

I'd like to know what exactly the difference is between Bill C‑368 and the one we're discussing, Bill C‑224.

4:50 p.m.

Conservative

Blaine Calkins Conservative Ponoka—Didsbury, AB

Thank you, Madame Gaudreau, for the question.

The significant difference when it comes to the text of the legislation between C-368, which basically just removed and reversed the clauses.... I believe it was 501 to 504 that were in Bill C-47. Because of the conversations that we had and as a result of the study of the bill and the debates in the House of Commons, two things stood out. One was the desire to have recall power, and the other was to remove nicotine from the health food perspective. Even though the way nicotine gets caught up in health food and natural products is that it's tobacco—so it's a natural product—it's not, from a health perspective, something that the Canadian Health Food Association or others would deem to be the same kind of product that we would have with other supplements or these kinds of things.

I could easily handle putting in the original part dealing with nicotine. I left it to the committee and to the House to debate how they wanted to handle the recall. I fully expected that it would be an amendment that would come forward, and I think that's something that this committee should be able to decide.

Marie-Hélène Gaudreau Bloc Laurentides—Labelle, QC

You just took the words right out of my mouth. That was my next question.

If it was agreed upon in the last Parliament, why didn't Bill C‑224 include the amendments regarding the minister's recall power to start with?

4:50 p.m.

Conservative

Blaine Calkins Conservative Ponoka—Didsbury, AB

I think there were some concerns after the bill was passed at committee last time about the wording that was used with some of the amendments. It wasn't the spirit of the amendments as much as it was the actual wording that was used, and if I remember correctly, we had some discussion. Peter Julian from the NDP had some amendments that he wanted to move forward as well that accidentally referred to natural health products as therapeutic products again. It created some confusion and concern. Just using that kind of language in the amendments, even though the intention was to extricate natural health products from Vanessa's Law, that reference in the language implied that natural health products were, in fact, therapeutic products.

I want the committee to get it right and, like I said, I thought I would leave that for the committee to decide. We would have some ideas on that. My colleagues from the Conservative side at least would have some ideas on that.

That's where I left that, Madame Gaudreau.